BNP (BrainNet Protocol) redefines the way cancer research is funded, managed, and accelerated. By integrating blockchain transparency, AI-powered data analysis, and tokenized incentives, BNP builds a decentralized ecosystem connecting donors, researchers, and patients worldwide. BNP Token enables transparent research funding, milestone-based rewards, and governance participation—driving global collaboration and innovation in cancer treatment.
BrainNet Protocol (BNP) is a blockchain-based healthcare ecosystem dedicated to advancing cancer research through transparent funding, AI-driven analytics, and community governance. Our mission is to build a decentralized framework that ensures secure medical data sharing, efficient fund allocation, and global collaboration among researchers and institutions. BNP bridges donors, patients, and scientists through tokenized funding and DAO governance, ensuring accountability, inclusivity, and impact across the cancer treatment landscape.
BNP enables transparent research funding with milestone-based rewards, ensuring every contribution is traceable and every research milestone is verifiable.
Advanced AI tools assist researchers in data analysis, predictive modeling, and experimental optimization—accelerating the discovery of effective therapies.
BNP adopts a community-driven DAO model, where token holders vote on research priorities, funding allocations, and ecosystem expansion.
BNP connects hospitals, biotech firms, and researchers worldwide, fostering knowledge sharing and accelerating treatment innovation.
BNP implements multi-layered cybersecurity, smart contract audits, and strict compliance with international medical data protection standards.
BNP revolutionizes cancer research through blockchain transparency, AI-powered analytics, and decentralized governance, creating a more efficient and collaborative healthcare ecosystem.
BNP leverages blockchain to ensure every contribution is traceable and every research milestone is verifiable. Donors can monitor fund utilization in real time.
Advanced AI tools assist researchers in data analysis, predictive modeling, and experimental optimization—accelerating the discovery of effective therapies.
BNP adopts a community-driven DAO model, where token holders vote on research priorities, funding allocations, and ecosystem expansion, ensuring transparency and fairness.
Token holders can stake BNP to support specific cancer research programs and receive milestone-based rewards, aligning incentives with scientific progress.
BNP connects hospitals, biotech firms, and researchers worldwide, fostering knowledge sharing and accelerating treatment innovation.
BNP implements multi-layered cybersecurity, smart contract audits, and strict compliance with international medical data protection standards (GDPR, HIPAA).
The issuance and distribution model of the BNP token is designed to support a dynamic and sustainable blockchain financial ecosystem.
Alexander Sterling — Chief Executive Officer (CEO)
Visionary leader overseeing BNP's global strategy, research partnerships, and blockchain innovation.
Dr. Elaine Parker — Chief Medical Officer (CMO)
Leading cancer researcher and clinical advisor responsible for research integrity and medical collaboration.
Nathan Cole — Chief Technology Officer (CTO)
Expert in blockchain architecture and AI system integration, ensuring platform scalability and data security.
Sophia Grant — Chief Operations Officer (COO)
Manages partnerships with hospitals, biotech firms, and global contributors to ensure efficient ecosystem development.
Composed of oncology specialists, data scientists, and blockchain security experts guiding BNP's sustainable growth.